Remdesivir for the treatment of COVID-19-Reference-Cited by-同舟云学术

Remdesivir for the treatment of COVID-19

Published:2023-01-25 Issue:1 Volume:2023 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Grundeis Felicitas¹,Ansems Kelly²,Dahms Karolina²,Thieme Volker¹,Metzendorf Maria-Inti³,Skoetz Nicole⁴,Benstoem Carina²,Mikolajewska Agata⁵⁶,Griesel Mirko¹,Fichtner Falk¹,Stegemann Miriam⁶

Affiliation:

1. Department of Anaesthesiology and Intensive Care; University of Leipzig Medical Center; Leipzig Germany

2. Department of Intensive Care Medicine and Intermediate Care; Medical Faculty, RWTH Aachen University; Aachen Germany

3. Institute of General Practice; Medical Faculty of the Heinrich-Heine-University Düsseldorf; Düsseldorf Germany

4. Cochrane Haematology, Department I of Internal Medicine; University of Cologne, Faculty of Medicine and University Hospital Cologne; Cologne Germany

5. Centre for Biological Threats and Special Pathogens (ZBS), Strategy and Incident Response, Clinical Management and Infection Control; Robert Koch Institute; Berlin Germany

6. Department of Infectious Diseases and Respiratory Medicine; Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin; Berlin Germany

Publisher

Wiley

Subject

Pharmacology (medical)

Reference240 articles.

1. Remdesivir for the treatment of COVID-19 - final report;Beigel;New England Journal of Medicine,2020

2. Remdesivir for the treatment of COVID-19 - preliminary report;Beigel;New England Journal of Medicine,2020

3. Beigel JH Tomashek KM Dodd LE Remdesivir for the treatment of COVID-19 - preliminary report New England Journal of Medicine 10.1056/NEJMc2022236 32649078

4. Epstein M Avoiding the termination of ACTT European Heart Journal 2020 10.1093/eurheartj/ehaa546

5. A multicenter, adaptive, randomised blinded controlled trial of the safety and efficacy of investigational therapeutics for the treatment of COVID-19 in hospitalised adults - version for European Union/United Kingdom sites www.clinicaltrialsregister.eu/ctr-search/search?query=EUCTR2020-001052-18-DE

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The treatment of COVID-19: lessons learned and future directions;Future Virology;2024-08-12

2. Comparative analysis of the safety and effectiveness of Nirmatrelvir-Ritonavir and Azvudine in older patients with COVID-19: a retrospective study from a tertiary hospital in China;Frontiers in Pharmacology;2024-07-22

3. Network-based Multi-omics Disease–Drug Associations Reveal Drug Repurposing Candidates for Covid-19 Disease Phases;Drug Repurposing;2024-07-03

4. The effect of early remdesivir administration in COVID-19 disease progression in hospitalised patients;Wiener klinische Wochenschrift;2024-06-17

5. Quality control in SARS-CoV-2 RBD-Fc vaccine production using LC–MS to confirm strain selection and detect contaminations from other strains;Scientific Reports;2024-04-26